Privatization of Sputnik V vaccine is just a farce and could be a real blessing.

India has been Kenya’s life saver in supplying AstraZeneca manufactured from Serum Institute of India for the first doze. Now the heavily populated country is itself facing a crisis of having severely been affected with the third wave of Coronavirus, thereby restricting exports to other nations.

Kenya now faces a halt in the administration of the AstraZeneca vaccine due to delays in the supply chain system. The initial plan was to reach 500,000 people with two doses of the 1.02 million doses received from the Covax facility on March 3, but plans were changed to reach at least one million people in the hope that the second consignment of the vaccine would be received in April to facilitate the second dosage.

This crisis will force Kenya to relook at the strategy they adopted with immediate effect in terms of banning import and distribution of vaccines by private companies. There has been a public outcry in the cost of these vaccines that have been imported; however, the cost of logistics has been unaccounted for. Nevertheless, Kenyan government; with increase in covid positive cases and no quick solution in the forefront must lift the ban to allow private companies to import and distribute these vaccines and streamline the entire process.

It is indeed a pity that the foresightedness of private healthcare owners has been seen in poor light in the same level as that of scam.

#JayeshSaini #nhif #healthcarecartels #afyacartels #kemsa #bliss#nairobiwest #Kenya #dinlas #clinix